A persistent and costly gap exists between how well AI performs in controlled research settings and how it actually functions in living clinical environments — and that gap directly affects patient safety and care quality. Bridging this divide may be among the most consequential challenges in modern medicine, touching every hospital system investing in automation.
This editorial synthesis in Cureus argues that the dominant evaluation metric for clinical AI — predictive accuracy measured in retrospective datasets — is functionally misleading as a proxy for real-world utility. In actual healthcare workflows, systems face documentation fragmentation, inconsistent data quality, interface friction, and competing cognitive demands on clinicians. These conditions degrade AI effectiveness and paradoxically worsen outcomes by generating alert fatigue and administrative drag. The authors advocate for a redesign philosophy centered on workflow-aware architecture, tiered information delivery, and mandatory accountability structures including EHR watermarking and continuous audit trails to track AI-generated documentation.
This argument reflects a maturing conversation in health informatics. Early AI enthusiasm focused heavily on benchmark performance — often on curated datasets that bear little resemblance to messy real-world records. The field is now grappling with implementation science, and this editorial contributes a useful conceptual frame: AI should function as a supportive cognitive layer, not an autonomous decision system. That distinction has significant medicolegal weight. Several high-profile deployments, including early sepsis prediction tools, have shown measurable accuracy in silico but generated alarm fatigue in practice, sometimes eroding clinician trust entirely. The audit trail and watermarking proposals here deserve particular attention, as they address accountability gaps that existing regulatory frameworks have yet to resolve. The primary limitation of this work is its editorial nature — it lacks empirical data, systematic methodology, or comparative analysis of real-world deployments. It is a conceptual argument, valuable for framing but not for clinical policy on its own. Incremental in contribution, though well-timed given the pace of AI adoption.